According to a previous study, neuroglobin attenuated tau hyperphosphorylation by activating the Akt signaling pathway in Tg2576 (AD mice) and TgMapt (human tau over-expression mice) models, and it suggested a therapeutic target for AD [44]. Here, MAPT is linked to Alzheimer disease.